About us

Edit Content

Chairman’s message

Edit Content

CEO Interview

Edit Content

Our Purpose

Chairman’s message

CEO Interview

Our Purpose

People

Edit Content

Shinya Moriuchi

Edit Content

Miriam Padilla​

Edit Content

Jennifer Alcock

Edit Content

Shinya Moriuchi​

Miriam Padilla​​

Jennifer Alcock​​​

Diego Martinez

Business Lines

Edit Content

Hemostasis

Edit Content

Acute Care Diagnostics

Edit Content

Autoimmunity

Edit Content

Original Equipment Manufacturing

Hemostasis

Acute Care Diagnostics

Autoimmunity

Original Equipment Manufacturing

Commercial Operations

Edit Content

Chief Commercial Officer’s message

Edit Content

North America

Edit Content

Europe

Edit Content

Latin America

Edit Content

EEMEA

Edit Content

APAC

Edit Content

China

Chief Commercial Officer’s message

North America

Europe

Latin America

EEMEA

APAC

China

Innovation

Edit Content

Hemostasis & Acute Care Diagnostics

Edit Content

Autoimmunity

Edit Content

OEM

Edit Content

VP Digital Solutions’ message

Hemostasis & Acute Care Diagnostics

Autoimmunity

OEM

VP Digital Solutions’ message

Spotlight

Edit Content

We Venture Capital

Edit Content

Chief Information Officer’s message

We Venture Capital

Chief Information Officer’s message

We Venture Capital

Chief Information Officer’s message

2022 Highlights

Izasa Medical, thanks to its highly diverse portfolio, achieved growth of 5% over 2020, despite a reduction in demand for personal protective equipment which boosted sales in 2020, due to the pandemic.

2022 Highlights

Izasa Scientific had an outstanding year, exceeding the 2020 results across almost all its business lines. The main growth driver was the private sector, thanks in large part to the new commercial strategy implemented in 2019, more oriented to the different needs of each of its target markets.

2022 Highlights

MC Medical, continued expanding its installed base of ventilators for ICUs and inked a new partnership in the Orthopedics field with Syntellix.

2022 Highlights

Nicolai continued expanding its presence in the gastrointestinal business while launching a new product line in the Interventional Cardiology field.

rotate your devicePlease rotate your device